Stability and in vitro release profile of enalapril maleate from different commercially available tablets: Possible therapeutic implications

Journal of Pharmaceutical and Biomedical Analysis

Volumn 47, Issue 4-5, 2008, Pages 934-937

  Lima, Dione Marçal ^a   dos Santos, Leandro Dias ^a   Lima, Eliana Martins ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Drug release; Enalapril; Pharmaceutical dosage forms; Stability

Indexed keywords

ENALAPRIL MALEATE; ENALAPRILAT;

ARTICLE; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DETERMINATION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; PRIORITY JOURNAL; REFERENCE VALUE; TABLET FORMULATION;

ACETONITRILES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL AVAILABILITY; BUFFERS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSAGE FORMS; DRUG STABILITY; ENALAPRIL; GUIDELINES AS TOPIC; HUMIDITY; HYDROGEN-ION CONCENTRATION; MOLECULAR STRUCTURE; PHARMACOPOEIAS AS TOPIC; PHOSPHATES; POWDERS; REFERENCE STANDARDS; SOLUBILITY; TABLETS; TEMPERATURE; THERAPEUTIC EQUIVALENCY;

EID: 44749087059     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.02.030     Document Type: Article

References (28)

1. Allen L.V., Popovich N.G., and Ansel H.C. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems. 8th ed. (2004), Lippincott Williams & Wilkins
2. Risha P.G., Vervaet C., Vergote G., Van Bortel L., and Remon J.P. Eur. J. Clin. Pharmacol. 59 (2003) 135-141
3. Lusina M., Cindric T., Tomaic J., Peko M., Pozaic L., and Musulin N. Int. J. Pharm. 291 (2005) 127-137
4. Murthy K.S., and Ghebre-Sellassie I.J. J. Pharm. Sci. 82 (1993) 113-126
5. Storpirtis S., Marcolongo R., Gasparotto F.S., and Vilanova C.M. Infarma 16 (2004) 51-56
6. Public Law 9787: establishes generic drugs policy and regulates generic denominations for pharmaceutical products, Brazil, 1999.
7. Guideline on registration requirements to establish interchangeability, WHO Technical Support Series, World Health Organization, 1996.
8. Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products-general considerations, US Center for Rug Evaluation and Research, Food and Drug Administration, 2002.
9. Dighe S.V. Transplant. Proc. 31 (1999) 23S-24S
10. Guideline on registration requirements for similar products (Res. N. 133), ANVISA-MS, Brazil, 2003.
11. Meredith P. Clin. Ther. 25 (2003) 2875-2890
12. Crawford P., Feely M., Guberman A., and Kramer G. Seizure 15 (2006) 165-176
13. MacFadyen R.J., Meredith P.A., and Elliott H.L. Clin. Pharmacokinet. 25 (1993) 274-282
14. Stanisz B.J. J. Pharm. Biomed. Anal. 31 (2003) 375-380
15. Edeki T., Johnston A., Li Kam Wa E., and Turner P. Int. J. Clin. Pharmacol. Ther. 32 (1994) 142-146
16. Espinel C.H., Williams J.L., and Coughlin S.S. Clin. Ther. 12 (1990) 181-190
17. Sato T., Takeshi M., and Yamamoto A. Circ. J. 56 (1992) 35-45
18. Al-Omari M.M., Abdelah M.K., Badwan A.A., and Jaber A.M. J. Pharm. Biomed. Anal. 25 (2001) 893-902
19. Qin X.Z., DeMarco J., and Ip D.P. J. Chromatogr. A 707 (1995) 245-254
20. Bhardwaj S.P., and Singh S. J. Pharm. Biomed. Anal. 46 (2008) 113-120
21. International Conference on Harmonization, ICH Q1 A (R2): stability testing of news drugs substance and products, published in Federal Register, 2003, pp. 16-31.
22. Guideline on pharmaceutical stability studies (Res. N. 1), ANVISA-MS, Brazil, 2005.
23. United States Pharmacopeia 27, National formulary, United States Pharmacopeia Convention, Rockville, 2004.
24. Guideline on in vitro pharmaceutical equivalency and dissolution studies protocol (Res. N. 310), ANVISA-MS, Brasil, 2004.
25. Dressman J.B., Amidon G.L., Reppas C., and Shah V.P. Pharm. Res. 15 (1998) 11-22
26. Jackson K., Young D., and Pant S. Pharm. Sci. Technol. Today 3 (2000) 336-345
27. Albonico M., Mathema P., Montresor A., Khakurel B., Reggi V., Pandey S., and Savioli L. Trans. R. Soc. Trop. Med. Hyg. 101 (2007) 454-460
28. Recommendations on stability studies in a global environment, Document QAS/05.146, World Health Organization, 2004.